IRLAB Therapeutics Correlations
| IRLAB-A Stock | SEK 14.75 0.20 1.34% |
The current 90-days correlation between IRLAB Therapeutics and Cantargia AB is 0.14 (i.e., Average diversification). The correlation of IRLAB Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
IRLAB Therapeutics Correlation With Market
Average diversification
The correlation between IRLAB Therapeutics AB and DJI is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding IRLAB Therapeutics AB and DJI in the same portfolio, assuming nothing else is changed.
IRLAB |
The ability to find closely correlated positions to IRLAB Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace IRLAB Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back IRLAB Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling IRLAB Therapeutics AB to buy it.
Moving together with IRLAB Stock
Moving against IRLAB Stock
| 0.49 | EGTX | Egetis Therapeutics | PairCorr |
| 0.34 | HNSA | Hansa Biopharma AB Earnings Call This Week | PairCorr |
| 0.33 | AAC | AAC Clyde Space | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between IRLAB Stock performing well and IRLAB Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze IRLAB Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CANTA | 2.08 | (0.65) | 0.00 | 2.01 | 0.00 | 2.29 | 36.56 | |||
| VICO | 2.21 | 0.34 | 0.07 | (0.44) | 2.45 | 7.13 | 16.91 | |||
| BINV | 2.35 | (0.80) | 0.00 | (1.96) | 0.00 | 4.94 | 19.33 | |||
| BIOA-B | 3.24 | 1.01 | 0.25 | (1.38) | 2.70 | 8.80 | 39.02 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in IRLAB Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
IRLAB Therapeutics Corporate Management
Elected by the shareholders, the IRLAB Therapeutics' board of directors comprises two types of representatives: IRLAB Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IRLAB. The board's role is to monitor IRLAB Therapeutics' management team and ensure that shareholders' interests are well served. IRLAB Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IRLAB Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nicholas Waters | Ex RD | Profile | |
| Maria Jalmelid | Chief Operations | Profile | |
| Joakim MD | Chief Officer | Profile | |
| Richard MBA | Chief Officer | Profile | |
| BSc BSc | Director HR | Profile | |
| Clas Sonesson | Chief Officer | Profile | |
| Viktor Siewertz | Chief Officer | Profile |